相关实验视频

Updated: Jul 11, 2026

From Constructs to Crystals – Towards Structure Determination of β-barrel Outer Membrane Proteins

From Constructs to Crystals – Towards Structure Determination of β-barrel Outer Membrane Proteins

Published on: July 4, 2016

针对Yersinia enterocolitica的in silico疫苗设计:一个全面的方法来提高免疫性,疗效和保护

Munazza Kanwal¹, Amina Basheer¹, Muhammad Bilal²

¹Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.

International immunopharmacology

|October 6, 2024

概括

这项研究使用反向疫苗学开发了一种针对Yersinia enterocolitica的新型多表位疫苗. 计算分析证实了它的稳定性,免疫性和广泛的人口覆盖,提供了对这种食源性病原体的有希望的战略.

科学领域:

* 传染病传染病
* 疫苗学疫苗学疫苗学
* 计算生物学 * 计算生物学

背景情况:

*Yersinia enterocolitica是日益严重的公共卫生威胁,原因是其患病率和多药性耐药性增加.
*有效的疫苗对于控制Yersinia enterocolitica感染至关重要.
*需要新的策略来对抗这种重要的食物传播病原体.

研究的目的:

*使用反向疫苗学识别和设计一种针对Yersinia enterocolitica的新型候选疫苗.
*以计算方式评估拟议疫苗的免疫性潜力和结构稳定性.
* 评估疫苗在不同的人群中的适用性.

主要方法:

*在体中逆向疫苗接种方法针对保存的SecY蛋白质.
* 间位素预测 (B细胞,MHC I类,MHC II类) 和多间位素疫苗结构设计.
* 计算分析包括物理化学性质,结构稳定性 (PDBSum,trRosetta),TLR4相互作用 (ClusPro),人口覆盖率,分子动力学模拟,以及用于表达的克隆.

主要成果:

*从SecY蛋白中确定了多个B细胞,MHC I类和MHC II类表位.
* 设计了一种稳定的多位疫苗结构,具有有利的物理化学特性和TLR4激动剂辅助潜力.
* 证明了高的人口覆盖率 (99.74%),结构稳定性和在大肠杆菌中表达的潜力.

结论:

* 在基设计的多层疫苗显示显著的希望作为对抗Yersinia enterocolitica的候选人.
* 该研究为进一步实验开发有效的Yersinia enterocolitica疫苗提供了坚实的计算基础.
*反向疫苗学提供了一种有效的策略,用于开发针对具有挑战性的食源病原体的疫苗.

关键词:

在形分析中进行了分析.分子对接是分子对接.多种药物耐药性耐多种药物耐药性多种表位疫苗的疫苗.反向接种疫苗的方法这种植物是Yersinia enterocolitica.这是一种Yersiniosis.

更多相关视频

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

相关概念视频

Vaccinations

Vaccinations

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...